EXCLUSIVE: Trump’s former FDA nominee vowed new abortion pill safety review after pressure from Sen Hawley
Food and Drug Administration nominee Dr. Heidi Overton committed to a timeline for a delayed mifepristone safety study, Sen. Josh Hawley's office says.
Covered by 1 source ·
Every side
-
Fox News
Food and Drug Administration nominee Dr. Heidi Overton committed to a timeline for a delayed mifepristone safety study, Sen. Josh Hawley's office says.